- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
The eyeforpharma Awards 2019: Nominations OPEN NOW
Nominations for the 2019 eyeforpharma awards are currently open.
In a world where true value matters and trust is critical; what are we rewarding?
It’s time for pharma to show its true colors and provide the maximum value to the greatest number of patients.
As we transform our industry, it’s vital to support the best work - and support it today, in 2019.
Nominations are now open for the eyeforpharma Awards 2019 - Click HERE to find out more.
We have 13 categories including new awards that celebrate innovation, disruption, entrepreneurs and pioneers.
How are you adding value? Find out how you can reward and be rewarded - Click HERE to find out more.
Categories include:
• New: Most Promising Pilot
This award is for an experimental initiative which has the potential to disrupt the status quo.
• New: Most Valuable Education/Awareness Initiative
This award is for an initiative that has raised the profile and visibility of a disease, cause, health concern, population or treatment.
• New: Most Valuable Data & Insights Initiative
This award is for an initiative that harnesses data (internal or RWD), AI, ML or analytics to reveal valuable insights, ultimately resulting in new opportunities for better patient care.
• Most Valuable Healthcare/HCP Initiative
The winner of this award will be an innovative project which has delivered tangible working and healthcare improvements, both in the long and short term, to healthcare professionals.
• Most Valuable Collaboration
The winner of this award will be the creator of a pharma-pharma or pharma-non pharma initiative which clearly brings a new proposition to either HCPs, payers and/or healthcare systems.
Download your Entry Pack here to find out more.
If you have any questions about the eyeforpharma Awards 2019, email Liz Swift at eswift@eyeforpharma.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
